From: Uptake of new antidiabetic medicines in 11 European countries
Country | Volume market share in 2016 | Annual therapy cost in 2016 | ||||
---|---|---|---|---|---|---|
New antidiabetic medicinesa (%) | All insulins (%) | Old antidiabetic medicines (%) | New antidiabetic medicinesa (€) | All insulins (€) | Old antidiabetic medicines (€) | |
Austria | 26.1 (20.8)b | 24.1 | 49.8 | 460 | 326 | 55.8 |
Croatia | 10.8 (8.7)b | 20.8 | 68.4 | 371 | 270 | 36.9 |
France | 17.7 (14.6)b | 21.1 | 61.3 | 480 | 386 | 56.6 |
Germany | 22.9 (17.5)b | 36.2 | 40.9 | 513 | 500 | 32.1 |
Hungary | 10.3 (7.5)b | 26.5 | 63.2 | 474 | 239 | 45.1 |
Italy | 8.8 (6.3)b | 21.5 | 69.7 | 499 | 326 | 43.3 |
Poland | 1.5 (1.1)b | 23.5 | 75.0 | 363 | 173 | 26.9 |
Slovenia | 6.6 (4.1)b | 29.0 | 63.5 | 427 | 284 | 58.0 |
Spain | 26.3 (21.2)b | 23.4 | 50.3 | 456 | 328 | 25.7 |
Sweden | 9.7 (5.8)b | 35.2 | 55.1 | 769 | 373 | 15.9 |
UK | 10.6 (6.8)b | 22.2 | 67.2 | 668 | 390 | 56.2 |